KRAS and lung carcinoma: The prognostic value of such sensitive detected K-Ras mutations when tacking into account the tumour cellularity, has still to be evaluated on an increased number of surgically treated lung cancer patients, taking into account the frequency of mutated allele in the sample depending on the tumour cellularity.